Estrella ImmunopharmaESLA
13F holders, Q3 2024 (September 30)10holders +3
3new positions
0sold out
1famous investor
$1.16avg. 13F price*
At the end of Q3 2024, 10 institutions reported holding Estrella Immunopharma Inc. (ESLA) in their 13F filings, up 3 from Q2 2024. 3 opened new positions and 0 sold out. The largest holders were Geode Capital Management, LLC ($89K), Atw Spac Management LLC ($46K) and BlackRock, Inc. ($29K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Estrella Immunopharma Inc.
- CUSIP
- 297584104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $50K |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 61,086 shares bought and 1,423 shares sold, net +59,663 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Geode Capital Management, LLC | 0.00% | Add +31.5% | 76,556 | $89K |
| Atw Spac Management LLC | 0.05% | No change | 40,000 | $46K |
| BlackRock, Inc. | 0.00% | — | 24,963 | $29K |
| Vanguard Group Inc. | 0.00% | New | 21,684 | $25K |
| Citadel Advisors | 0.00% | New | 14,531 | $17K |
| MASO CAPITAL PARTNERS Ltd | 0.01% | No change | 10,000 | $12K |
| UBS Group AG | 0.00% | New | 6,523 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -19.9% | 5,728 | $7K |
| Bank of America Corp. | 0.00% | Add +6.4% | 83 | $96 |
| JPMorgan Chase & Co. | 0.00% | Add +3.9% | 27 | $31 |
"% of holder's portfolio" is ESLA's weight in each manager's 13F, not the share of Estrella Immunopharma Inc. the manager owns.